Sustainability is more than a buzzword in the Life Science industry. Regulatory authorities, customers and users closely watch the activities of every company in this market.
Sustainability is a central competitive and reputation factor for Siegfried, and carries a high economic value. We take the expectations of all stakeholders for transparency and honesty seriously. The Board of Directors and Group management contributed to the Report, and they will continue to implement improvements to ensure a high standard of information.
Within the range of relevant sustainability topics, Siegfried focuses on Compliance and Quality, Safety, Health and Environment (SHE), and our responsibility as an employer. As a relatively modest sized company in the Life Science industry, Siegfried has little influence in how the ingredients produced at our facilities are used and consequently, has little contact with the end user. This limits our scope of action.
Siegfried offers a capability unique in our market: the development and production of active pharmaceutical ingredients and finished dosage forms under one roof. Both competencies are based on the same compliance system. The combination of synthesis and formulation represents an attractive market opportunity for the long-term viability of the company (and jobs). This strength was placed at the heart of the "Transform" strategy and our communications activities; this strategic alignment can be seen in sizeable investments in the infrastructure.